Skip to main content
Equibles

Kimberly Graper

CFO

Imunon, Inc. (IMNN)

Equibles does not estimate personal net worth.

Get an email with a short summary when Imunon, Inc. publishes a filing, an earnings call transcript or a press release.

Get IMNN alerts

About Kimberly Graper

Kimberly Graper is recorded as CFO at Imunon, Inc. (IMNN) since June 13, 2025. Imunon, Inc. reported in an 8-K filed January 7, 2026 that Kimberly Graper resigned as interim Chief Financial Officer, effective January 14, 2026. Imunon, Inc. reported in an 8-K filed June 13, 2025 that Kimberly Graper was appointed interim Chief Financial Officer, effective June 13, 2025. Imunon, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Imunon, Inc. includes Corinne Le Goff (CEO and Board Member), Michael Tardugno (CEO and Chairman), Stacy Lindborg (CEO and Board Member) and 7 others.

“On January 7, 2026, Imunon, Inc. (the “Company”) announced that Kimberly Graper, its interim Chief Financial Officer, will be resigning from her role effective January 14, 2026.”
Imunon, Inc. Form 8-K, filed January 7, 2026 · Read the filing
“As a result of the termination of the Agreement and Mr. Gaiero's related service, effective June 13, 2025, the Company appointed Kimberly Graper to serve as the Company's interim Chief Financial Officer.”
Imunon, Inc. Form 8-K, filed June 13, 2025 · Read the filing

Affiliation history

Company network

Imunon, Inc.

IMNN

Current role

Biotechnology · Healthcare

CFO

2025-06-13–present

Leadership on record at Imunon, Inc.

Recent activity